They identified the genomic alterations and significant amplification of known cancer driver genes, such as KRAS, FGFR2, MET, ERBB2, EGFR, MYC, CCND1, and CD44 in GC with peritoneal metastasis [10]. The gene discussed is CD44; the disease is cancer.